-
of oncologic agents under development, providing unique insights into the patient experience of symptomatic adverse events that traditional clinical assessments may miss. Our published proof-of-concept study
-
in vitro and in vivo infection models, flow cytometry, ELISA, western blots, and multiplex immunoassays. Our projects rely on successful partnerships with collaborators across academia and government
Searches related to agent based model
Enter an email to receive alerts for agent-based-model positions